Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine ( 18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer-Reference-Cited by-同舟云学术

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine ( 18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer

Published:2017-03 Issue:3 Part 1 Volume:197 Page:676-683
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bach-Gansmo Tore¹,Nanni Cristina²,Nieh Peter T.³,Zanoni Lucia²,Bogsrud Tronde Velde¹,Sletten Heidi¹,Korsan Katrine Andersen¹,Kieboom J.⁴,Tade Funmilayo I.⁵,Odewole Oluwaseun⁵,Chau Albert⁶,Ward Penelope⁶,Goodman Mark M.⁵,Fanti Stefano²,Schuster David M.⁵,Willoch Frode⁴⁷

Affiliation:

1. Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

2. Nuclear Medicine, Azienda ospedaliero-universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy

3. Department of Urology, Emory University, Atlanta, Georgia

4. Department of Nuclear Medicine and Radiology, Aleris Healthcare, Oslo, Norway

5. Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia

6. Blue Earth Diagnostics, Oxford, United Kingdom

7. Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. American Cancer Society: Cancer Facts & Figures 2016. Available at http://www.cancer.org/research/cancerfactsstatistics. Accessed April 14, 2016.

2. Guideline for the management of clinically localized prostate cancer;Thompson;J Urol,2007

3. Current controversies in the management of biochemical failure in prostate cancer;Bruce;Clin Adv Hematol Oncol,2012

4. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

5. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy;Simmons;Eur Urol,2007

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States;PharmacoEconomics;2023-11-07

2. Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate;Médecine Nucléaire;2023-10

3. Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives;Cancers;2023-09-27

4. Salvage Whole-Pelvic Radiation and Long-Term Androgen-Deprivation Therapy in the Management of High-Risk Prostate Cancer: Long-Term Update of the McGill 0913 Study;Current Oncology;2023-08-01

5. Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review;Diagnostics;2023-07-05